Farms.com Home   News

Researchers Target Lawsonia Intracellularis

The Western College of Veterinary Medicine and the Vaccine and Infectious Disease Organization are working to help pork producers around the world address Lawsonia intracellularis, one of the pork sector's most common bacterial infections. Researchers with the Western College of Veterinary Medicine and the Vaccine and Infectious Disease Organization are using a variety of techniques to identify antigens that can be used in the development of safe and effective subunit vaccines to prevent Lawsonia intracellularis.

Kezia Fourie, a PhD Student with the Western College of Veterinary Medicine, says these bacteria are prevalent around the world so the goal is to create a safe and effective subunit vaccine to help producers clear the infection from their barns and give them some economic relief.

Clip-Kezia Fourie-Western College of Veterinary Medicine:

Lawsonia intracellularis or Lawsonia for short is a bacteria that infects the intestines of pigs. One of the biggest symptoms is slower weight gain. This has both an economic and an animal health impact. In terms of animal health, the animal cannot absorb its nutrients from its food as readily as it should so it gains weight a lot slower than usual and this also has an economic impact.

The producer has to spend more money and more time to get that animal to its market weight so it can go to slaughter. A little bit of slower weight gain may not sound as big of an issue but, when you think about how many pigs a producer is going through, that cost adds up over time.

In terms of prevalence, it's found in barns all around the world and, depending on what country you're looking at, you're going to see different prevalences. For some countries it's as low as 10 percent but for other countries it can be as high as 90, which is what it is in North America.

Source : Farmscape

Trending Video

New Solution Powers Efficient Pork Growth

Video: New Solution Powers Efficient Pork Growth


Alltech has introduced Olerix, an innovative phytogenic blend created to promote growth and feed efficiency in pigs. Through a proprietary coating process, the bioactive blend of phytogenic compounds used in Olerix is designed to outlast the manufacturing process, ensuring consistent outcomes from feed to finish. The result is a high-impact efficiency solution that provides consistent support for gut health, feed efficiency, immune function and growth performance. Olerix is backed by validated trials conducted under modern pork production conditions.

“As the industry searches for technology to drive profitability forward in a more sustainable manner, we’re thrilled to join that effort with our Olerix technology,” said Mark Hulsebus, general manager for U.S. pork at Alltech. “Our work in this phytogenic space is yielding very encouraging results, and we’re excited to make this new opportunity available to pork producers focused on optimizing feed efficiency and growth rates.”

“Olerix represents the next generation of phytogenic technology — combining feed efficiency, livability and immune support into a practical commercial solution producers can implement today,” said Andy Rash, U.S. monogastric director at Alltech.